It’s not only who we are but also what we want to achieve.

When we hear from current customers that cNeuro has provided the information they need for confident, evidence-based decisions for their patients, we know that we’re on the right track. Yet, we are constantly looking forward to addressing the next challenge, whether that’s aiding with patient selection for clinical trials of disease-modifying drugs for Alzheimer’s disease or putting tools directly in the hands of patients.